Li Xiyan, Li Chuangji, Su Mengxi, Zhong Xinyi, Xing Yihan, Shan Zhengjie, Chen Shoucheng, Liu Xingchen, Wu Xiayi, Liu Quan, Li Ye, Wu Shiyu, Chen Zhuofan
Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China.
Guangdong Provincial Key Laboratory of Stomatology, Guangzhou, China.
Sci Technol Adv Mater. 2023 Mar 13;24(1):2186690. doi: 10.1080/14686996.2023.2186690. eCollection 2023.
Biogenic collagen membranes (BCM) have been widely used in guided bone regeneration (GBR) owing to their biodegradability during tissue integration. However, their relatively high degradation rate and lack of pro-osteogenic properties limit their clinical outcomes. It is of great importance to endow BCM with tailored degradation as well as pro-osteogenic properties. In this study, a fluoride-modified polymer-induced liquid precursor (PILP) based biomineralization strategy was used to convert the collagen membrane from an organic phase to an apatite-based inorganic phase, thus achieving enhanced anti-degradation performance as well as osteogenesis. As a result, three phases of collagen membranes were prepared. The original BCM in the organic phase induced the mildest inflammatory response and was mostly degraded after 4 weeks. The organic-inorganic mixture phase of the collagen membrane evoked a prominent inflammatory response owing to the fluoride-containing amorphous calcium phosphate (F-ACP) nanoparticles, resulting in active angiogenesis and fibrous encapsulation, whereas the inorganic phase induced a mild inflammatory response and degraded the least owing to the transition of F-ACP particles into calcium phosphate with high crystallinity. Effective control of ACP is key to building novel apatite-based barrier membranes. The current results may pave the way for the development of advanced apatite-based membranes with enhanced barrier performances.
生物源性胶原膜(BCM)因其在组织整合过程中的生物可降解性而被广泛应用于引导骨再生(GBR)。然而,其相对较高的降解速率和缺乏促骨生成特性限制了其临床效果。赋予BCM定制的降解性能以及促骨生成特性至关重要。在本研究中,采用了一种基于氟化物改性聚合物诱导液体前驱体(PILP)的生物矿化策略,将胶原膜从有机相转化为磷灰石基无机相,从而实现增强的抗降解性能和成骨能力。结果,制备了三个阶段的胶原膜。有机相中的原始BCM引发的炎症反应最轻微,4周后大部分降解。胶原膜的有机-无机混合相由于含氟无定形磷酸钙(F-ACP)纳米颗粒而引发显著的炎症反应,导致活跃的血管生成和纤维包裹,而无机相引发的炎症反应较轻,由于F-ACP颗粒转变为高结晶度的磷酸钙,降解最少。有效控制ACP是构建新型磷灰石基屏障膜的关键。目前的结果可能为开发具有增强屏障性能的先进磷灰石基膜铺平道路。